These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 9525598)
1. Plasma membrane-targeted Raf kinase activates NF-kappaB and human immunodeficiency virus type 1 replication in T lymphocytes. Flory E; Weber CK; Chen P; Hoffmeyer A; Jassoy C; Rapp UR J Virol; 1998 Apr; 72(4):2788-94. PubMed ID: 9525598 [TBL] [Abstract][Full Text] [Related]
2. Raf-1 kinase targets GA-binding protein in transcriptional regulation of the human immunodeficiency virus type 1 promoter. Flory E; Hoffmeyer A; Smola U; Rapp UR; Bruder JT J Virol; 1996 Apr; 70(4):2260-8. PubMed ID: 8642652 [TBL] [Abstract][Full Text] [Related]
3. ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kappaB. Yang X; Chen Y; Gabuzda D J Biol Chem; 1999 Sep; 274(39):27981-8. PubMed ID: 10488148 [TBL] [Abstract][Full Text] [Related]
4. Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway. Popik W; Hesselgesser JE; Pitha PM J Virol; 1998 Aug; 72(8):6406-13. PubMed ID: 9658081 [TBL] [Abstract][Full Text] [Related]
5. A dominant role for the Raf-MEK pathway in forskolin, 12-O-tetradecanoyl-phorbol acetate, and platelet-derived growth factor-induced CREB (cAMP-responsive element-binding protein) activation, uncoupled from serine 133 phosphorylation in NIH 3T3 cells. Seternes OM; Johansen B; Moens U Mol Endocrinol; 1999 Jul; 13(7):1071-83. PubMed ID: 10406459 [TBL] [Abstract][Full Text] [Related]
6. Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). Koong AC; Chen EY; Mivechi NF; Denko NC; Stambrook P; Giaccia AJ Cancer Res; 1994 Oct; 54(20):5273-9. PubMed ID: 7923153 [TBL] [Abstract][Full Text] [Related]
7. The Ras-Raf pathway is activated in human immunodeficiency virus-infected monocytes and particpates in the activation of NF-kappa B. Folgueira L; Algeciras A; MacMorran WS; Bren GD; Paya CV J Virol; 1996 Apr; 70(4):2332-8. PubMed ID: 8642660 [TBL] [Abstract][Full Text] [Related]
8. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB. Tsatsanis C; Patriotis C; Tsichlis PN Oncogene; 1998 Nov; 17(20):2609-18. PubMed ID: 9840924 [TBL] [Abstract][Full Text] [Related]
9. Activation of Raf-1 and mitogen-activated protein kinase in murine macrophages partially mimics lipopolysaccharide-induced signaling events. Hambleton J; McMahon M; DeFranco AL J Exp Med; 1995 Jul; 182(1):147-54. PubMed ID: 7790814 [TBL] [Abstract][Full Text] [Related]
10. Oncogenic Ras enhances NF-kappaB transcriptional activity through Raf-dependent and Raf-independent mitogen-activated protein kinase signaling pathways. Norris JL; Baldwin AS J Biol Chem; 1999 May; 274(20):13841-6. PubMed ID: 10318790 [TBL] [Abstract][Full Text] [Related]
11. Activation of tissue-factor gene expression in breast carcinoma cells by stimulation of the RAF-ERK signaling pathway. Zhou JN; Ljungdahl S; Shoshan MC; Swedenborg J; Linder S Mol Carcinog; 1998 Apr; 21(4):234-43. PubMed ID: 9585253 [TBL] [Abstract][Full Text] [Related]
12. Interaction between c-Rel and the mitogen-activated protein kinase kinase kinase 1 signaling cascade in mediating kappaB enhancer activation. Meyer CF; Wang X; Chang C; Templeton D; Tan TH J Biol Chem; 1996 Apr; 271(15):8971-6. PubMed ID: 8621542 [TBL] [Abstract][Full Text] [Related]
13. Novel membrane-targeted ERK1 and ERK2 chimeras which act as dominant negative, isotype-specific mitogen-activated protein kinase inhibitors of Ras-Raf-mediated transcriptional activation of c-fos in NIH 3T3 cells. Hochholdinger F; Baier G; Nogalo A; Bauer B; Grunicke HH; Uberall F Mol Cell Biol; 1999 Dec; 19(12):8052-65. PubMed ID: 10567531 [TBL] [Abstract][Full Text] [Related]
14. Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes. Tuyt LM; Dokter WH; Birkenkamp K; Koopmans SB; Lummen C; Kruijer W; Vellenga E J Immunol; 1999 Apr; 162(8):4893-902. PubMed ID: 10202034 [TBL] [Abstract][Full Text] [Related]
15. The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway. Birkenkamp KU; Tuyt LM; Lummen C; Wierenga AT; Kruijer W; Vellenga E Br J Pharmacol; 2000 Sep; 131(1):99-107. PubMed ID: 10960075 [TBL] [Abstract][Full Text] [Related]
16. Different effects of point mutations within the B-Raf glycine-rich loop in colorectal tumors on mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase and nuclear factor kappaB pathway and cellular transformation. Ikenoue T; Hikiba Y; Kanai F; Aragaki J; Tanaka Y; Imamura J; Imamura T; Ohta M; Ijichi H; Tateishi K; Kawakami T; Matsumura M; Kawabe T; Omata M Cancer Res; 2004 May; 64(10):3428-35. PubMed ID: 15150094 [TBL] [Abstract][Full Text] [Related]
17. Activation of NF-kappa B by oncogenic Raf in HEK 293 cells occurs through autocrine recruitment of the stress kinase cascade. Troppmair J; Hartkamp J; Rapp UR Oncogene; 1998 Aug; 17(6):685-90. PubMed ID: 9715269 [TBL] [Abstract][Full Text] [Related]
18. Bradykinin B2 receptor mediates NF-kappaB activation and cyclooxygenase-2 expression via the Ras/Raf-1/ERK pathway in human airway epithelial cells. Chen BC; Yu CC; Lei HC; Chang MS; Hsu MJ; Huang CL; Chen MC; Sheu JR; Chen TF; Chen TL; Inoue H; Lin CH J Immunol; 2004 Oct; 173(8):5219-28. PubMed ID: 15470067 [TBL] [Abstract][Full Text] [Related]
19. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2. Wen-Sheng W Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661 [TBL] [Abstract][Full Text] [Related]
20. Relaxin, a pregnancy hormone, is a functional endothelin-1 antagonist: attenuation of endothelin-1-mediated vasoconstriction by stimulation of endothelin type-B receptor expression via ERK-1/2 and nuclear factor-kappaB. Dschietzig T; Bartsch C; Richter C; Laule M; Baumann G; Stangl K Circ Res; 2003 Jan; 92(1):32-40. PubMed ID: 12522118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]